Reliable in use, removable when needed – Next-gen adhesive solutions that can be precisely and residue-free removedInnovation hub with impact – Accelerating customer-specific developments...
Power Meets Precision in the Newest Innovation from the Bantam Carbon Series
NILES, Mich., June 30, 2025 /PRNewswire/ -- Paddletek, the trusted name in premium U.S.-made...
CHICHESTER, England, June 27, 2025 /PRNewswire/ -- Integrated Polymer Solutions, Inc. ("IPS"), a portfolio company of Arcline Investment Management ("Arcline"), today announced the acquisition...
HUNTSVILLE, AL, June 23, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, is pleased to announce that Chief Executive Officer Steve Ledger will present at an upcoming FORCE Family Office investor webinar titled "New Drug Optimization Platform to Transform Parkinson’s Care.” The Event is scheduled to take place on Thursday, June 26, 2025, at 12:00 p.m. ET / 9:00 a.m. PT.